{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:04:48Z","timestamp":1793505888377,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG instillation is a rare complication of therapy that is associated with significant morbidity and mortality. We conducted a multicenter retrospective review of microbiologically confirmed M.bovis BCG infections in Western Australia over 22 years. Thirty-three patients were included in our study. All patients were male with a median age of 72 years. Localized infections accounted for 22\/33 cases while disseminated infections accounted for 11\/33 cases. The majority (n = 21) of positive isolates were cultured from urine specimens, followed by tissue and blood. The median time between first BCG instillation and infection was 7.5 months (95% CI, 3.5\u201311.5). The median duration of antimycobacterial therapy for localized infections was 6 months (95% CI, 4.1\u20137.9) as compared with 9 months (95% CI, 7.9\u201310.1) for disseminated infections (P = .039). The attributed mortality was 14.3%. M.bovis BCG infections have diverse clinical presentations and clinicians must have a high index of suspicion when assessing patients with a history of intravesical BCG instillation.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf070","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:21:14Z","timestamp":1738729274000},"source":"Crossref","is-referenced-by-count":5,"title":["<i>Mycobacterium bovis<\/i> Infections Following Intravesical Bacillus Calmette-Gu\u00e9rin Instillation for Bladder Cancer in Western Australia: A 22-Year Retrospective Review"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9417-4076","authenticated-orcid":false,"given":"Usha","family":"Manickavasagar","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Sir Charles Gairdner Hospital , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-5371","authenticated-orcid":false,"given":"Henco","family":"Nel","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sir Charles Gairdner Hospital , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Seet","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sir Charles Gairdner Hospital , Perth ,","place":["Australia"]},{"name":"University of Western Australia , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9335-207X","authenticated-orcid":false,"given":"Liana","family":"Varrone","sequence":"additional","affiliation":[{"name":"Western Australian Department of Health , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terillee","family":"Keehner","sequence":"additional","affiliation":[{"name":"Mycobacterium Reference Laboratory, PathWest, Queen Elizabeth II Medical Centre , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"McCann","sequence":"additional","affiliation":[{"name":"Western Australian Department of Health , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Barnes","sequence":"additional","affiliation":[{"name":"Western Australian Department of Health , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0461-681X","authenticated-orcid":false,"given":"Angela","family":"Jacques","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sir Charles Gairdner Hospital , Perth ,","place":["Australia"]},{"name":"Institute of Health Research, The University of Notre Dame , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Clohessy","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sir Charles Gairdner Hospital , Perth ,","place":["Australia"]},{"name":"University of Western Australia , Perth ,","place":["Australia"]},{"name":"Western Australian Department of Health , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"2025022510062569900_ofaf070-B1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2025022510062569900_ofaf070-B2","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.juro.2016.10.101","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"197","author":"Morales","year":"2017","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU Int"},{"key":"2025022510062569900_ofaf070-B4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/bju.14793","article-title":"The epidemiology of bacille Calmette-Gu\u00e9rin infections after bladder instillation from 2002 through 2017: a nationwide retrospective cohort study","volume":"124","author":"Larsen","year":"2019","journal-title":"BJU Int"},{"key":"2025022510062569900_ofaf070-B5","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.idcr.2017.09.008","article-title":"Mycobacteria bovis osteomyelitis following intravesical BCG for bladder cancer","volume":"10","author":"Seegobin","year":"2017","journal-title":"IDCases"},{"key":"2025022510062569900_ofaf070-B7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B8","first-page":"325","article-title":"Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer","volume":"310","author":"Steg","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"2025022510062569900_ofaf070-B9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10067-019-04500-w","article-title":"Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases","volume":"38","author":"Cadiou","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025022510062569900_ofaf070-B10","author":"European Centre for Disease Prevention and Control"},{"key":"2025022510062569900_ofaf070-B11","author":"World Health Organization"},{"key":"2025022510062569900_ofaf070-B12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.ju.0000150425.09317.67","article-title":"Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer\u2013Genito-urinary Group phase III trial (30906)","volume":"173","author":"de Reijke","year":"2005","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B13","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/ajrccm\/146.5_Pt_1.1330","article-title":"Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Gu\u00e9rin immunotherapy","volume":"146","author":"McParland","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2025022510062569900_ofaf070-B15","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0022-5347(17)35824-X","article-title":"Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin","volume":"150","author":"Izes","year":"1993","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.juro.2006.03.066","article-title":"Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients","volume":"176","author":"Yossepowitch","year":"2006","journal-title":"J Urol"},{"key":"2025022510062569900_ofaf070-B17","author":"O\u2019Donnell"},{"key":"2025022510062569900_ofaf070-B18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol Ther"},{"key":"2025022510062569900_ofaf070-B19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cid\/cix496","article-title":"Healthcare-associated Mycobacterium bovis\u2013bacille Calmette-Gu\u00e9rin (BCG) infection in cancer patients without prior BCG instillation","volume":"65","author":"Meije","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf070\/61790839\/ofaf070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/2\/ofaf070\/61790839\/ofaf070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/2\/ofaf070\/61790839\/ofaf070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:06:45Z","timestamp":1740478005000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf070\/8004994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf070","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,31]]},"article-number":"ofaf070"}}